Riskpilot← Back to searchSign inGet full accessNyt Syn, Vejle ApS
APSActiveCVR 40301836Nørregade 10CRetail sale of medical and orthopaedic goods · NACE 4774Est. 20193 employees
Revenue 2025
DKK 2,2M
+32% vs 2024
EBITDA margin
29.4%
+11% vs 2024
Equity ratio
56.7%
Financial strength
Net profit 2025
DKK 490K
+39% vs 2024
| Revenue | DKK 2,2M | +32% |
| EBITDA | DKK 658K | +11% |
| Net profit | DKK 490K | +39% |
| Total assets | DKK 1,2M | +38% |
| Equity | DKK 692K | +38% |
| Employees | 3 | — |
Legal name
Nyt Syn, Vejle ApS
CVR number
40301836
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
1. marts 2019
Share capital
DKK 50.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 direktører i forening.
Company purpose
Selskabets formål er at drive detailvirksomhed med optiske produkter.
Address
Nørregade 10C
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.147 | 1.236 | 1.893 | 1.704 | 1.694 | 2.241 |
| Staff expenses | -1.087 | -1.061 | -1.538 | -1.856 | -1.100 | -1.583 |
| EBITDA | 60 | 175 | 355 | -158 | 594 | 658 |
| Depreciation & amort. | -100 | -75 | -79 | -83 | -58 | -8 |
| EBIT | -40 | 100 | 276 | -241 | 536 | 650 |
| Net financials | -78 | -15 | -14 | -12 | -21 | -9 |
| Profit before tax | -117 | 86 | 262 | -253 | 515 | 641 |
| Tax | -17 | 21 | 64 | -99 | 162 | 151 |
| Net profit | -100 | 64 | 199 | -154 | 353 | 490 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 1.118 | 844 | 972 | 903 | 884 | 1.221 |
| Equity | 300 | 364 | 503 | 149 | 502 | 692 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 819 | 480 | 469 | 754 | 382 | 529 |
| Total debt | 819 | 480 | 469 | 754 | 382 | 529 |
EBITDA margin
29.4%
This company
15.8%
Market median
+86% vs market
20202025
Equity ratio
56.7%
This company
38.2%
Market median
+48% vs market
20202025
Return on equity
70.8%
This company
18.4%
Market median
+285% vs market
20202025
Net profit margin
21.9%
This company
8.1%
Market median
+170% vs market
20202025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20202025
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-03-01 – 2020-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IH Management | Management | 2019 | — | — |
TS Management | Management | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hasselbrinck Schmidt Holding ApS | Company | 50.0% | 50.0% | 2019 |
Svarrer Ankersen Holding ApS | Company | 50.0% | 50.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hasselbrinck Schmidt Holding ApS
Nyt Syn, Vejle ApS Board members of Nyt Syn, Vejle ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ivan Hasselbrinck Schmidt | Management | 0 companies |
| Thomas Svarrer Ankersen | Management | 0 companies |